Multifocal motor neuropathy with conduction block: a study of 24 patients.
P. Bouché(Immune Regulation (United Kingdom)), G Saïd(Sorbonne Université), Vincent Meininger(Générale de Santé), David Adams(Université Paris-Sud), A Moulonguet(Sorbonne Université), Nicole Baumann(Inserm), J.-M. Léger(Sorbonne Université), Amena Ben Younes‐Chennoufi(Sorbonne Université)
Cited by 178
Related Papers
Patisiran, an RNAi Therapeutic, for Hereditary Transthyretin Amyloidosis
|New England Journal of Medicine|2018|2.9k
A Controlled Trial of Riluzole in Amyotrophic Lateral Sclerosis
|New England Journal of Medicine|1994|2.2k
TARDBP mutations in individuals with sporadic and familial amyotrophic lateral sclerosis
|Nature Genetics|2008|1.5k
Inotersen Treatment for Patients with Hereditary Transthyretin Amyloidosis
|New England Journal of Medicine|2018|1.4k
Dose-ranging study of riluzole in amyotrophic lateral sclerosis
|The Lancet|1996|1.3k